Guselkumab effective through 2 years in PsA trial
Crossref DOI link: https://doi.org/10.1038/s41584-021-00733-9
Published Online: 2021-12-03
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Onuora, Sarah
Text and Data Mining valid from 2021-12-03
Version of Record valid from 2021-12-03
Article History
First Online: 3 December 2021